Boundless Bio, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Boundless Bio, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($13.88M) | Nov 5, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($15.68M) | Aug 5, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($15.76M) | May 9, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($16.51M) | Nov 5, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($16.98M) | Aug 5, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($15.43M) | May 9, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($13.17M) | Nov 7, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($12.40M) | Aug 12, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($11.72M) | May 13, 2024 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($15.15M) | Nov 5, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($17.06M) | Aug 5, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($17.34M) | May 9, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($18.72M) | Nov 5, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($19.39M) | Aug 5, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($16.88M) | May 9, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($14.95M) | Nov 7, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($13.96M) | Aug 12, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($12.09M) | May 13, 2024 |